What is Qianjiang Yongan Pharmaceutical Co., Ltd.'s (002365.SZ) StockRank?

MoatMap's StockRank for Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) is 27/100, with a Sell signal. This is a composite score combining Quality (59), Value (28), and Momentum (32) factor ranks across MoatMap's 20,000+ stock universe.

Does Qianjiang Yongan Pharmaceutical Co., Ltd. have an economic moat?

Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Qianjiang Yongan Pharmaceutical Co., Ltd. a buy, hold, or sell?

MoatMap's current signal for Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Qianjiang Yongan Pharmaceutical Co., Ltd. in?

Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

002365.SZ

SELLREMOVE

Qianjiang Yongan Pharmaceutical Co., Ltd. · Healthcare · China · $512M · Avg Vol: $11M/d

StockRank

P/E (TTM)

90.4x

ROE

1.1%

D/E

0.0x

Dividend %

0.9%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

A major producer of taurine that operates as a low-moat commodity chemical business rather than a high-value CDMO or specialty healthcare provider.

COMPANY DESCRIPTION

Qianjiang Yongan Pharmaceutical Co., Ltd. is the world's largest manufacturer of taurine, an essential amino acid used in energy drinks, infant formula, and animal feed. The company's formidable competitive moat is built on its massive production scale, advanced environmental treatment facilities, and a global market share exceeding 50%. It operates as a dominant, highly profitable niche leader in the global food and feed additive industry.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	216M	144M	124M	116M	-18.8%
EPS	0.07	-0.01	0.03	0.01	-45.4%
Shares	295M	295M	295M	295M	0.0%
Debt	6M	1M	6M	110,845	-73.4%
Equity	298M	293M	295M	294M	-0.5%
Op CF	57M	33M	16M	21M	-28.9%
Inv CF	-34M	-21M	-7M	-18M	—
Fin CF	3M	-10M	-6M	-16M	—

PRICE (1M)-23.8%

SMA 50SMA 200

$1.58

RSI (14)

26.7

52W High

$4.69

From 52W High

0.3%

SCORE BREAKDOWN

Quality

ROIC

0.5%45.4

ROE

1.1%46.7

GP/Assets

7.4%22.0

Op. Margin

5.5%56.0

FCF/Assets

1.6%56.3

Piotroski

—83.4

Int. Cover

11.5x66.7

D/E Ratio

0.00x98.8

Current Ratio

5.95x76.1

Value

P/E (TTM)

90.4x10.2

EV/EBITDA

16.9x23.5

P/FCF

661.5x11.9

P/B

1.6x64.5

P/S

3.8x49.1

Div Yield

0.9%25.0

Momentum

52W High %

34%7.9

RS 6M

-41%29.7

SMA 50/200

0.83x17.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

—96.7

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$512M

P/E (Forward)

13.2x

Gross Margin

19.1%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 002365.SZ are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
002365.SZ	Qianjiang Yongan Pharmaceutical Co., Ltd.(you)	$512M	27	SELL
300584.SZ	Nanjing Hicin Pharmaceutical Co., Ltd.	$612M	26	SELL
300485.SZ	Beijing Science Sun Pharmaceutical Co., Ltd.	$634M	26	SELL
688247.SS	Sinotherapeutics Inc.	$571M	32	SELL
002793.SZ	Luoxin Pharmaceuticals Group Stock Co., Ltd.	$690M	30	SELL
301277.SZ	Newland Pharmaceutical Co., Ltd.	$574M	34	SELL
002728.SZ	Teyi Pharmaceutical Group Co.,Ltd	$671M	32	SELL
688621.SS	Beijing Sun-Novo Pharmaceutical Research Co., Ltd.	$894M	26	SELL
002038.SZ	Beijing SL Pharmaceutical Co., Ltd.	$893M	28	SELL
002907.SZ	Chongqing Pharscin Pharmaceutical Co., Ltd.	$765M	31	SELL

Peer medians: ROE 4.8% · P/E 27.6x · Gross margin 53.1%

Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) — Stock Score Summary

Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) has a MoatMap StockRank of 27/100 based on Quality (59/100), Value (28/100), and Momentum (32/100) factor scores. The current signal is SELL. A major producer of taurine that operates as a low-moat commodity chemical business rather than a high-value CDMO or specialty healthcare provider.

Key Financial Metrics

Price	$1.58
Market Cap	$512M
P/E (TTM)	90.42
P/E (Forward)	13.23
Price/Book	1.57
Return on Equity	1.1%
Return on Invested Capital	0.5%
Debt/Equity	0.04
Gross Margin	19.1%
Operating Margin	5.5%
Revenue Growth	37.8%
Dividend Yield	0.9%
Free Cash Flow	$774K

Qianjiang Yongan Pharmaceutical Co., Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Qianjiang Yongan Pharmaceutical Co., Ltd.’s (002365.SZ) StockRank?: MoatMap’s StockRank for Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) is 27/100, with a Sell signal. It is a composite of Quality (59), Value (28), and Momentum (32) factor ranks across MoatMap’s 20,000+ stock universe.
Does Qianjiang Yongan Pharmaceutical Co., Ltd. have an economic moat?: Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) has a Quality factor score of 59/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Qianjiang Yongan Pharmaceutical Co., Ltd. a buy, hold, or sell?: MoatMap’s current signal for Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) is Sell, based on a StockRank of 27/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Qianjiang Yongan Pharmaceutical Co., Ltd. in?: Qianjiang Yongan Pharmaceutical Co., Ltd. (002365.SZ) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).